Next report date
Report period
Q2 2024
EPS estimate
−0.20SEK
Revenue estimate
2.10 MSEK
−1.29SEK
−89.32 MSEK
7.63 MSEK
111.49 M
About MEDIVIR AB
Sector
CEO
Jens Lindberg
Headquarters
Huddinge
Website
Employees (FY)
10
Founded
1987
ISIN
SE0020181014
FIGI
BBG00JHVVCV6
Medivir AB engages in the development of pharmaceuticals products. The firm focuses on the discovery and development of transformative active cancer drugs. Its portfolio includes proprietary pipelines such as remetinostat, birinapant, MV-818, MV-828, and MIV-711 projects, and partnership pipeline which covers xerclear and MIV-802 project. The company was founded in 1988 and is headquartered in Huddinge, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 0GP7 is 2.93 SEK — it has decreased by 9.58% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange MEDIVIR AB NPV stocks are traded under the ticker 0GP7.
MEDIVIR AB NPV is going to release the next earnings report on Aug 22, 2024. Keep track of upcoming events with our Earnings Calendar.
0GP7 stock is 10.59% volatile and has beta coefficient of 0.68. Check out the list of the most volatile stocks — is MEDIVIR AB NPV there?
0GP7 earnings for the last quarter are −0.28 SEK per share, whereas the estimation was −0.37 SEK resulting in a 23.53% surprise. The estimated earnings for the next quarter are −0.24 SEK per share. See more details about MEDIVIR AB NPV earnings.
MEDIVIR AB NPV revenue for the last quarter amounts to 4.40 M SEK despite the estimated figure of 800.00 K SEK. In the next quarter revenue is expected to reach 1.90 M SEK.
Yes, you can track MEDIVIR AB NPV financials in yearly and quarterly reports right on TradingView.
0GP7 net income for the last quarter is −20.30 M SEK, while the quarter before that showed −23.60 M SEK of net income which accounts for 13.98% change. Track more MEDIVIR AB NPV financial stats to get the full picture.
Today MEDIVIR AB NPV has the market capitalization of 356.29 M, it has increased by 3.47% over the last week.
No, 0GP7 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0GP7 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDIVIR AB NPV stock right from TradingView charts — choose your broker and connect to your account.
As of May 1, 2024, the company has 10.00 employees. See our rating of the largest employees — is MEDIVIR AB NPV on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDIVIR AB NPV technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDIVIR AB NPV stock shows the sell signal. See more of MEDIVIR AB NPV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on MEDIVIR AB NPV future price: according to them, 0GP7 price has a max estimate of 54.00 SEK and a min estimate of 10.45 SEK. Read a more detailed MEDIVIR AB NPV forecast: see what analysts think of MEDIVIR AB NPV and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDIVIR AB NPV EBITDA is −88.60 M SEK, and current EBITDA margin is −1.16 K%. See more stats in MEDIVIR AB NPV financial statements.